Anchiano Therapeutics Ltd. reported consolidated earnings results for fourth quarter and full year ended December 31, 2018. For the quarter, the company reported net loss of approximately $1.8 million against $1.9 million a year ago. Operating loss was $2,976,000 against $1,882,000 a year ago. For the full year, the company reported net loss of approximately $13.3 million or $1.05 per ordinary share against $9.8 million or $1.09 per ordinary share a year ago. Operating loss was $13,044,000 against $9,392,000 a year ago.